Table 1.

Five-year cancer-specific survival for node-positive disease following nephroureterectomy and lymph node dissection.

	Number of node-positive patients	Five-year cancer-specific survival
Johansson and Wahlqvist [19]	N/A	0%
Secin et al. [15]	28	0%
Miyake et al. [17]	13	0%
Novara et al. [7]	27	12%
Kondo et al. [14]	42	15%
Park et al. [20]	11	27%
Roscigno et al. [16]	26	39%